PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer — Stella

Recruiting

Back to Prostate Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Miami, Miami, Florida

Key details

Phase

Safety & dosing

Sponsor

University of Miami

Enrollment target

~34 participants

Started

July 2024

Primary completion

August 2027

Age range

18 Years and older

Sex

Male only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov